Picard Medical Q1 revenue up 85% to $1.2M; reports $1.4M negative equity, NYSE listing notices

Picard Medical, Inc.

Revenue $1.2M (+85% YoY); gross profit $0.3M (24% margin) vs gross loss of $0.4M in Q1 2025.
Net loss $7.6M including non-cash debt settlement and fair value charges.
Reduced senior secured note balance from ~$10.8M to ~$1.3M via cash, equity, and cashless transactions.
Subsequent public offering raised $5.0M gross; warrant exchange replaced 7M high-price warrants with 10M at $0.35.
Received NYSE American non-compliance notices for equity standards (deficit $1.4M); must submit plan by June 7, 2026.

item 2.02 item 3.01 item 7.01 item 9.01

Featured in Daily 8-K Digest

Selected #6 for 2026-05-21. Read digest

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001829126-26-005568
form_type: 8-K
ticker: PMI
cik: 0002030617
company_name: Picard Medical, Inc.
filed_at: 2026-05-21T20:15:19+00:00
discovered_at: 2026-05-21T20:17:00.353051+00:00
generated_at: 2026-05-21T22:07:27.969232+00:00
sec_items: ["2.02", "3.01", "7.01", "9.01"]
event_type: other_material
sentiment: negative
materiality_score: 0.85
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001829126-26-005568
json_url: https://secwatch.observer/filing/0001829126-26-005568.json
markdown_url: https://secwatch.observer/filing/0001829126-26-005568.md
text_url: https://secwatch.observer/filing/0001829126-26-005568.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/2030617/000182912626005568/0001829126-26-005568-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/2030617/000182912626005568/picardmedical_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source-grounded claims

9638e56796d182445e2295256575a08562e110c4

Picard Medical, Inc. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(i), 1003(a)(ii)).

On May 15, 2026, the Company received a written notice (the “May 15 Notice”) from the NYSE American LLC (the “NYSE American”) indicating that the Company is not in compliance with the NYSE American continued listing standards set forth in Section 1003(a)(i) of the NYSE American Company Guide (the “Company Guide”), which requires a listed company to have stockholders’ equity of at least of $2.0 million if it has reported losses from continuing operations and/or net losses in two of its three most recent fiscal years. The May 15 Notice states that the Company reported a stockholders’ deficit of approximately $1.4 million as of March 31, 2026 and has incurred losses from continuing operations and/or net losses in its three most recent fiscal years ended December 31, 2025. Additionally, as previously disclosed, on May 8, 2026, the Company received a notice that it was not in compliance with Section 1003(a)(ii) (the “May 8 Notice,” and together with the May 15 Notice, the “ Notices ”). In c

SEC 8-K Item 3.01 confidence 0.95 SEC evidence

Source: SEC EDGAR

accession 0001829126-26-005568

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.